MAPK1 and pancreatic neoplasm: These results are in keeping with a number of reports that have examined the relative expression and activity of Erk1 and Erk2 in human malignancies such as colonic and pancreatic cancer (Attar et al, 1996; Yip-Schneider et al, 1999).